• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一系列新型含硫醇抑制剂对氨肽酶A活性位点进行研究。

Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.

作者信息

Chauvel E N, Coric P, Llorens-Cortès C, Wilk S, Roques B P, Fournié-Zaluski M C

机构信息

Unité de Pharmacochimie Moléculaire et Structurale, U266 INSERM, URA D 1500 CNRS, Université René Descartes, UFR des sciences pharmaceutiques et biologiques, Paris, France.

出版信息

J Med Chem. 1994 Apr 29;37(9):1339-46. doi: 10.1021/jm00035a014.

DOI:10.1021/jm00035a014
PMID:7909847
Abstract

Aminopeptidase A (APA) and aminopeptidase N (APN) are two metallopeptidases which have been suggested to be involved in the enzymatic cascade of the renin-angiotensin system. APA liberates angotensin III from angiotensin II by releasing the N-terminal aspartate, and APN participates in the inactivation of angiotensin III. As the role of angiotensin III in the regulation of blood pressure in the central nervous system and at the periphery is controversial, it was of interest to develop selective and efficient inhibitors of APA. Starting from Glu-thiol(1), which was the first efficient APA inhibitor described, but however is equipotent on APA (Ki = 0.14 microM) and APN (Ki = 0.12 microM), beta-amino thiols bearing various carboxyalkyl chains have been synthesized and their inhibitory potencies measured on both purified enzymes. Compounds containing a carboxylated aromatic ring inhibited APA and APN with Ki values in the micromolar range but were slightly more active on APA. Conversely, inhibitors containing a cyclohexyl ring were more efficient on APN. Various modifications of the structure of Glu-thiol decreased inhibitory activity on both enzymes but increased the selectivity for APA, and compound 9d ((S)-4-amino-6-mercaptohexanoic acid) was 23 times more potent on APA (Ki = 2.0 microM) than on APN (Ki = 45 microM).

摘要

氨肽酶A(APA)和氨肽酶N(APN)是两种金属肽酶,有人认为它们参与肾素 - 血管紧张素系统的酶促级联反应。APA通过释放N端天冬氨酸从血管紧张素II中释放出血管紧张素III,而APN参与血管紧张素III的失活。由于血管紧张素III在中枢神经系统和外周血压调节中的作用存在争议,因此开发选择性高效的APA抑制剂很有意义。从Glu-硫醇(1)开始,它是首个被描述的高效APA抑制剂,但对APA(Ki = 0.14 microM)和APN(Ki = 0.12 microM)的效力相同,已合成了带有各种羧基烷基链的β-氨基硫醇,并测定了它们对两种纯化酶的抑制效力。含有羧化芳环的化合物对APA和APN的抑制作用,其Ki值在微摩尔范围内,但对APA的活性略高。相反,含有环己基环的抑制剂对APN更有效。Glu-硫醇结构的各种修饰降低了对两种酶的抑制活性,但增加了对APA的选择性,化合物9d((S)-4-氨基-6-巯基己酸)对APA(Ki = 2.0 microM)的效力比对APN(Ki = 45 microM)高23倍。

相似文献

1
Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.使用一系列新型含硫醇抑制剂对氨肽酶A活性位点进行研究。
J Med Chem. 1994 Apr 29;37(9):1339-46. doi: 10.1021/jm00035a014.
2
Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols.新型β-氨基硫醇对氨肽酶A和氨肽酶N的差异性抑制作用
J Med Chem. 1994 Sep 2;37(18):2950-7. doi: 10.1021/jm00044a016.
3
Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.氨肽酶A可生成脑肾素-血管紧张素系统的主要效应肽之一——血管紧张素III,在动脉血压的中枢控制中起关键作用。
Biochem Soc Trans. 2000;28(4):435-40.
4
Potent and selective inhibition of zinc aminopeptidase A (EC 3.4.11.7, APA) by glutamyl aminophosphinic peptides: importance of glutamyl aminophosphinic residue in the P1 position.谷氨酰氨基次膦酸肽对锌氨肽酶A(EC 3.4.11.7,APA)的强效选择性抑制作用:P1位谷氨酰氨基次膦酸残基的重要性
Biochemistry. 2000 Feb 8;39(5):1152-5. doi: 10.1021/bi9922345.
5
Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.基于活性位点研究设计的强效且具有全身活性的氨肽酶N抑制剂。
J Med Chem. 1992 Apr 3;35(7):1259-66. doi: 10.1021/jm00085a013.
6
Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids.酸性氨基酸硫醇衍生物对血管紧张素III形成的抑制作用。
Neuropeptides. 1990 Jul;16(3):163-8. doi: 10.1016/0143-4179(90)90129-m.
7
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.使用特定氨肽酶抑制剂鉴定脑内血管紧张素II和III的代谢途径:血管紧张素III在控制血管加压素释放中的主要作用
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11968-73. doi: 10.1073/pnas.93.21.11968.
8
PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III.PC18是一种特异性氨肽酶N抑制剂,它通过延长脑内血管紧张素III的半衰期来诱导抗利尿激素释放。
Neuroendocrinology. 1999 May;69(5):370-6. doi: 10.1159/000054439.
9
Histidine 450 plays a critical role in catalysis and, with Ca2+, contributes to the substrate specificity of aminopeptidase A.组氨酸450在催化过程中起关键作用,并与钙离子一起,对氨肽酶A的底物特异性有影响。
Biochemistry. 2000 Mar 21;39(11):3061-8. doi: 10.1021/bi9925726.
10
[Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].[脑内血管紧张素II和血管紧张素III代谢途径的鉴定:血管紧张素III在血管加压素分泌控制中的主要作用]
C R Seances Soc Biol Fil. 1998;192(4):607-18.

引用本文的文献

1
IRAP Inhibitors: M1-Aminopeptidase Family Inspiration.IRAP抑制剂:M1-氨基肽酶家族的启发。
Front Pharmacol. 2020 Sep 25;11:585930. doi: 10.3389/fphar.2020.585930. eCollection 2020.
2
Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases.基于氨苯并噻唑酮骨架的模块化化学工具抑制治疗相关 M1 氨肽酶。
Molecules. 2018 Oct 11;23(10):2607. doi: 10.3390/molecules23102607.
3
Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
QGC001(一种中枢作用的氨肽酶A抑制剂前药)的随机、双盲、安慰剂对照、剂量递增的I期研究
Clin Pharmacokinet. 2014 Apr;53(4):385-95. doi: 10.1007/s40262-013-0125-y.
4
Metallo-aminopeptidase inhibitors.金属蛋白酶抑制剂。
Biochimie. 2010 Nov;92(11):1509-29. doi: 10.1016/j.biochi.2010.04.026. Epub 2010 May 10.
5
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.分布式药物发现,第2部分:用于合成树脂结合的非天然氨基酸的烷基化剂的全局演练及虚拟D(3)目录构建。
J Comb Chem. 2009 Jan-Feb;11(1):14-33. doi: 10.1021/cc800184v.
6
Aminopeptidase A inhibitors as centrally acting antihypertensive agents.氨肽酶A抑制剂作为中枢性抗高血压药物。
Heart Fail Rev. 2008 Sep;13(3):311-9. doi: 10.1007/s10741-007-9077-3. Epub 2008 Jan 3.
7
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.氨肽酶-N/CD13(EC 3.4.11.2)抑制剂:化学、生物学评价及治疗前景
Med Res Rev. 2006 Jan;26(1):88-130. doi: 10.1002/med.20044.
8
Role of angiotensin III in hypertension.血管紧张素III在高血压中的作用。
Curr Hypertens Rep. 2005 Apr;7(2):128-34. doi: 10.1007/s11906-005-0087-z.
9
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.全身活性氨肽酶A抑制剂对脑肾素-血管紧张素系统的阻断作用:盐依赖性高血压的一种潜在治疗方法。
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7775-80. doi: 10.1073/pnas.0402312101. Epub 2004 May 10.
10
Aminopeptidase A inhibitors as potential central antihypertensive agents.氨肽酶A抑制剂作为潜在的中枢性抗高血压药物。
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13415-20. doi: 10.1073/pnas.96.23.13415.